Evercore ISI Group Upgrades Enanta Pharmaceuticals to Outperform, Announces $62 Price Target
Evercore ISI Group analyst Liisa Bayko upgrades Enanta Pharmaceuticals (NASDAQ:ENTA) from In-Line to Outperform and announces $62 price target.
Mizuho Maintains Neutral on Highwoods Props, Lowers Price Target to $37
Mizuho analyst Vikram Malhotra maintains Highwoods Props (NYSE:HIW) with a Neutral and lowers the price target from $46 to $37.
Truist Securities Initiates Coverage On Howmet Aerospace with Buy Rating, Announces Price Target of $41
Truist Securities analyst Michael Ciarmoli initiates coverage on Howmet Aerospace (NYSE:HWM) with a Buy rating and announces Price Target of $41.
Maxim Group Initiates Coverage On Aclarion with Buy Rating, Announces Price Target of $3
Maxim Group analyst Anthony Vendetti initiates coverage on Aclarion (NASDAQ:ACON) with a Buy rating and announces Price Target of $3.
CL King Initiates Coverage On Materion with Buy Rating, Announces Price Target of $95
CL King analyst David Silver initiates coverage on Materion (NYSE:MTRN) with a Buy rating and announces Price Target of $95.
B of A Securities Upgrades Dun & Bradstreet Hldgs to Neutral, Raises Price Target to $17
B of A Securities analyst Heather Bellini upgrades Dun & Bradstreet Hldgs (NYSE:DNB) from Underperform to Neutral and raises the price target from $16 to $17.
Mizuho Maintains Buy on Boston Properties, Lowers Price Target to $105
Mizuho analyst Vikram Malhotra maintains Boston Properties (NYSE:BXP) with a Buy and lowers the price target from $135 to $105.
Argus Research Downgrades McCormick & Co to Hold
Argus Research analyst John Staszak downgrades McCormick & Co (NYSE:MKC) from Buy to Hold.
EF Hutton Initiates Coverage On Indonesia Energy Corp with Buy Rating, Announces Price Target of $11
EF Hutton analyst Ben Piggott initiates coverage on Indonesia Energy Corp (AMEX:INDO) with a Buy rating and announces Price Target of $11.
Morgan Stanley Maintains Equal-Weight on Cleveland-Cliffs, Lowers Price Target to $16
Morgan Stanley analyst Carlos De Alba maintains Cleveland-Cliffs (NYSE:CLF) with a Equal-Weight and lowers the price target from $24 to $16.